Massachusetts Biomedical Initiatives
Massachusetts Biomedical Initiatives: Strong Growth, High Program Spending
EIN: 222636406 · Worcester, MA · NTEE: U500 · Updated: 2026-04-04
Source Check Matrix
What Has Been Verified vs. What Needs Human Review
Identity resolved verified
Massachusetts Biomedical Initiatives is mapped to EIN 222636406.
IRS BMF exempt record needs review
Open IRS TEOS or BMF source before relying on exemption status.
IRS Pub 78 deductibility needs review
Pub 78 eligibility should be verified in IRS TEOS before money changes hands.
IRS automatic revocation needs review
Check the official auto-revocation bulk source or cached evidence before relying on current exemption.
IRS Form 990 index verified
13 stored filing years available.
Raw 990 source linked
Open ProPublica to verify the raw filing record and PDFs.
Filing depth verified
13 stored filing years available.
State charity registration manual confirmation
Open MA charity regulator via NASCO; the workflow stops for human confirmation unless a stable source is cached.
Candid / GuideStar profile api pending
Candid API access is not configured; open manually and do not count as verified evidence.
Charity Navigator rating api pending
Charity Navigator API access is not configured; open manually and do not count as verified evidence.
Source and Resolution Links
Finish the Investigation Outside Our Dataset
When the answer lives with the IRS, ProPublica, Candid, Charity Navigator, or the nonprofit itself, NonprofitSpending links out instead of trapping the user on a partial answer.
IRS tax-exempt lookup
Verify exemption status and deductibility directly with the IRS.
IRS bulk evidence downloads
Check Pub 78, automatic revocation, 990-N, and Form 990 bulk evidence sources.
IRS EO BMF extract
Open the official Business Master File extract source for tax-exempt organization records.
ProPublica 990 source
Open the raw filing record and filing PDFs outside NonprofitSpending.
MA charity regulator via NASCO
Confirm state charity registration or solicitation status where applicable.
Candid profile search
Look for GuideStar/Candid profile details, programs, leadership, and seals.
Charity Navigator search
Check whether another evaluator has ratings or impact context.
Workflow Engine
Queries We Should Resolve, Not Just Answer
Search Console demand points to task completion. Each workflow can run calculations, source checks, external lookups, comparisons, and report/export capture around this nonprofit.
Verify tax status Runnable
Triggered by: 501(c)(3), tax deductible, EIN
IRS status check plus source links
Verify official evidence Runnable
Triggered by: IRS Pub 78, BMF, revocation, 990 index, state registration
Official-source evidence matrix with human stops where a state portal must be checked.
Resolve tax deductibility Runnable
Triggered by: is my donation tax deductible, Pub 78, donor receipt
Pub 78, BMF, and revocation checks turned into a donor-safe deductibility path.
Check state solicitation Runnable
Triggered by: allowed to solicit, charity registration, state compliance
Official state regulator route with human confirmation when no reliable API exists.
Find source filings Runnable
Triggered by: 990 PDF, annual report, filing record
13 stored filing years plus ProPublica source
Crunch money signals Runnable
Triggered by: program expense ratio, CEO salary, revenue, grants
85% program spend, health grade A
Compare alternatives Runnable
Triggered by: best charities, similar nonprofits, compare
4 peer options surfaced
Resolve leadership and board Runnable
Triggered by: executive team, trustees, officer pay
Use 990 compensation disclosures and external profile links.
Analyze executive compensation Runnable
Triggered by: CEO salary, excessive compensation, officer pay
Officer-pay context against revenue, filings, state/category compensation, and source records.
Donation decision copilot Runnable
Triggered by: should I donate, give or compare, charity safety
Eligibility, money signals, sources, peer context, and next action.
Grantmaker due diligence Runnable
Triggered by: foundation review, grant risk, grantee capacity
Foundation-style packet across filings, finances, governance, and gaps.
Build grant/funder shortlist Runnable
Triggered by: find funders, grantee shortlist, mission fit
Geography, cause, evidence gaps, and peers converted into a funder/grantee action path.
Impact evidence finder Runnable
Triggered by: outcomes, annual report, cost effectiveness
Separate actual impact evidence from raw 990 financial cleanliness.
Room for more funding Runnable
Triggered by: would my donation help, funding gap, marginal impact
Revenue trend, runway, surplus/deficit, and source follow-ups.
Operator transparency diagnostic Runnable
Triggered by: how does my nonprofit look to donors
Profile, filing, impact, and transparency improvements to earn trust.
Create compliance monitor Runnable
Triggered by: watch new 990, revocation, Pub 78, registration changes
Monitoring plan for IRS status, new filings, revocation signals, and state follow-ups.
| Metric | Value |
|---|---|
| Total Revenue | $6.2M |
| Total Expenses | $3.6M |
| Program Spending | 85% |
| Net Assets | $20.9M |
| Transparency Score | 85/100 |
Search Intent Cockpit
Massachusetts Biomedical Initiatives Form 990, Revenue, CEO Pay, and IRS Filing Signals
Massachusetts Biomedical Initiatives is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around Massachusetts Biomedical Initiatives in one place.
Form 990 Filing Summary
13 filing years are available, with latest revenue of $6.4M and expenses of $3.6M.
Revenue and Expenses
Massachusetts Biomedical Initiatives reported $6.4M in revenue and $3.6M in expenses, a surplus of $2.8M.
Executive Compensation
Officer, director, trustee, and key employee pay is reviewed from IRS 990 compensation disclosures when present.
Charity Score and Red Flags
85/100 mission score, 0 red flags, and 4 strengths are shown from structured and AI review.
Is Massachusetts Biomedical Initiatives Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
IRS 990 Data Cockpit
Where the Money Comes From and Where It Goes
Revenue Source Mix
Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.
Expense Deployment
| Program services | $3.0M (85%) |
Across stored filings, Massachusetts Biomedical Initiatives shows contribution history pending. Next enrichment targets: revenue-source fields, IRS BMF classification.
Decision Cockpit
One-Stop Donor, Research, and Peer Context Hub
| Decision Lens | Signal | What to Inspect Next |
|---|---|---|
| Legitimacy | Appears Legitimate | Good filing record; no red flags identified |
| Mission spend | 85% to programs | Excellent |
| Financial durability | Grade A | 13 stored filing years |
| Peer context | Compare with Joint Committee For Childrens Health Care In Everett | Massachusetts and Category U context |
Trust Check
Review legitimacy, deductibility, red flags, and filing consistency.
Open charity check →Peer Benchmark
Compare against real state and category peers.
Compare with Joint Committee For Childrens Health Care In Everett →All Massachusetts nonprofits
All Category U
Local and Sector Spokes
Move into this nonprofit's local market, category, and sector maps.
Worcester, MA nonprofitsCategory U in Massachusetts
Public Benefit in Massachusetts
Follow the Money
Jump into spending, compensation, rankings, and filing-year evidence.
State spending analysisState compensation analysis
Category U spending
Best Category U charities in Massachusetts
Relevant rankings
Donation Decision Flow
From Trust Check to Better Alternatives
Alternative Shopping
Similar Nonprofits Donors Should Compare
North American Marine Alliance Inc
Gloucester, MA · $2.7M revenue · Score 95/100
Compare side-by-sideSharing Foundation
Concord, MA · $1.2M revenue · Score 95/100
Compare side-by-sideMarthas Vineyard Community Television Inc
Vineyard Hvn, MA · $877K revenue · Score 95/100
Compare side-by-sideGrowing Places Garden Project Inc
Leominster, MA · $2.1M revenue · Score 90/100
Compare side-by-sideNext Best Actions
Keep the Investigation Moving
Research Workflow
Turn this Form 990 profile into a donor-ready report
Request a concise report for Massachusetts Biomedical Initiatives with revenue, expenses, executive compensation, red flags, peer context, and IRS source links. You can also request CSV exports or watchlist updates for future filings.
Early access request only. Reports and exports are informational and based on public IRS records, not financial or legal advice.
Massachusetts Biomedical Initiatives directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Massachusetts Biomedical Initiatives
Massachusetts Biomedical Initiatives (EIN: 222636406) is a nonprofit organization based in Worcester, MA, classified under NTEE code U500. The organization reported total revenue of $6.2M and total assets of $31.3M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Massachusetts Biomedical Initiatives's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Massachusetts Biomedical Initiatives is a mid-size nonprofit that has been operating for 41 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 13.5%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $6.4M |
| Total Expenses | $3.6M |
| Surplus / Deficit | +$2.8M |
| Total Assets | $30.0M |
| Total Liabilities | $9.1M |
| Net Assets | $20.9M |
| Operating Margin | 43.9% |
| Debt-to-Asset Ratio | 30.3% |
| Months of Reserves | 100.8 months |
Financial Health Grade: A
In 2023, Massachusetts Biomedical Initiatives reported a surplus of $2.8M with revenue exceeding expenses, holds 100.8 months of operating reserves (strong position), has a debt-to-asset ratio of 30.3% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), Massachusetts Biomedical Initiatives's revenue has grown at a compound annual growth rate (CAGR) of 13.5%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +33.9% | +4.5% | +26.4% |
| 2022 | +9.6% | +19.1% | +28.1% |
| 2021 | -27.2% | +29.1% | +5.6% |
| 2020 | +111.5% | +19.1% | +36.6% |
| 2019 | +61.6% | +13.2% | +24.6% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 1985 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Massachusetts Biomedical Initiatives with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Massachusetts Biomedical Initiatives allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $2.8M, with revenue exceeding expenses.
- Debt-to-asset ratio: 30.3%.
Executive Compensation Analysis
Executive compensation is not explicitly detailed in the provided data, but the 0% compensation from related parties suggests a focus on mission rather than excessive insider payments.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for Massachusetts Biomedical Initiatives:
- Consistent revenue growth from $1.7M in 2016 to $6.3M in 2023, demonstrating increasing financial capacity.
- Significant asset growth from $10.2M in 2016 to $29.9M in 2023, indicating strong financial health and investment.
- Low liability-to-asset ratio, with liabilities at $9.0M against assets of $29.9M in 2023, suggesting good financial management.
- High percentage of expenses dedicated to programs (85%), indicating a strong focus on its core mission.
Frequently Asked Questions about Massachusetts Biomedical Initiatives
Is Massachusetts Biomedical Initiatives a legitimate charity?
Massachusetts Biomedical Initiatives (EIN: 222636406) is a registered tax-exempt nonprofit based in Massachusetts. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $6.2M. No red flags identified. 4 strengths noted. Financial health grade: A.
How does Massachusetts Biomedical Initiatives spend its money?
Massachusetts Biomedical Initiatives directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Massachusetts Biomedical Initiatives tax-deductible?
Massachusetts Biomedical Initiatives is registered as a tax-exempt nonprofit (EIN: 222636406). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Massachusetts Biomedical Initiatives's spending goes to programs?
Massachusetts Biomedical Initiatives directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Massachusetts Biomedical Initiatives compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), Massachusetts Biomedical Initiatives is above average for NTEE category U500 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Massachusetts Biomedical Initiatives located?
Massachusetts Biomedical Initiatives is headquartered in Worcester, Massachusetts and files with the IRS under EIN 222636406. It is classified under NTEE code U500.
How many years of IRS 990 filings does Massachusetts Biomedical Initiatives have?
Massachusetts Biomedical Initiatives has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $6.2M in total revenue.
What does Massachusetts Biomedical Initiatives do?
Massachusetts Biomedical Initiatives is a nonprofit organization in the Science & Technology sector, located in Worcester, Massachusetts. It is classified under NTEE code U500.
How much revenue does Massachusetts Biomedical Initiatives have?
Massachusetts Biomedical Initiatives reported total revenue of $6,194,356. Based on 13 IRS 990 filings on record.
What are Massachusetts Biomedical Initiatives's total assets?
Massachusetts Biomedical Initiatives holds total assets of $31,324,216 as reported in IRS 990 filings.
Where is Massachusetts Biomedical Initiatives located?
Massachusetts Biomedical Initiatives is based in Worcester, Massachusetts.
What is Massachusetts Biomedical Initiatives's EIN?
Massachusetts Biomedical Initiatives's Employer Identification Number (EIN) is 222636406. This is the unique tax ID assigned by the IRS for tax-exempt organizations.
What type of nonprofit is Massachusetts Biomedical Initiatives?
Massachusetts Biomedical Initiatives is classified under NTEE code U500 (Science & Technology).
Is Massachusetts Biomedical Initiatives a registered 501(c)(3)?
Yes, Massachusetts Biomedical Initiatives is recognized as a tax-exempt organization by the IRS. EIN: 222636406.
Does Massachusetts Biomedical Initiatives file IRS Form 990?
Yes, Massachusetts Biomedical Initiatives has 13 IRS Form 990 filings on record. The most recent covers tax period 202312.
What was Massachusetts Biomedical Initiatives's revenue in 2023?
In the 202312 filing period, Massachusetts Biomedical Initiatives reported total revenue of $6,363,451, total expenses of $3,568,461, and net assets of $29,972,322.
Is Massachusetts Biomedical Initiatives's revenue growing or declining?
Massachusetts Biomedical Initiatives's revenue is growing. Revenue went from $4,750,848 (202212) to $6,363,451 (202312), a +33.9% change. Based on 13 filings on record.
What is Massachusetts Biomedical Initiatives's most recent 990 filing?
The most recent IRS Form 990 filing for Massachusetts Biomedical Initiatives covers tax period 202312. It shows revenue of $6,363,451, expenses of $3,568,461, total assets of $29,972,322, and liabilities of $9,085,090.
How much does Massachusetts Biomedical Initiatives spend on programs vs administration?
Based on IRS 990 analysis, Massachusetts Biomedical Initiatives allocates approximately 85% of expenses to program services, 10% to administrative costs, and 5% to fundraising. This indicates strong program focus.
Is Massachusetts Biomedical Initiatives a trustworthy charity?
Based on AI analysis of IRS 990 data, Massachusetts Biomedical Initiatives appears trustworthy. Mission Score: 85/100 (Excellent). No red flags identified. 4 strengths noted.
What are Massachusetts Biomedical Initiatives's strengths?
Positive indicators for Massachusetts Biomedical Initiatives include: Consistent revenue growth from $1.7M in 2016 to $6.3M in 2023, demonstrating increasing financial capacity.. Significant asset growth from $10.2M in 2016 to $29.9M in 2023, indicating strong financial health and investment.. Low liability-to-asset ratio, with liabilities at $9.0M against assets of $29.9M in 2023, suggesting good financial management.. High percentage of expenses dedicated to programs (85%), indicating a strong focus on its core mission.. These findings are derived from AI analysis of the organization's financial filings.
How does Massachusetts Biomedical Initiatives compensate executives?
Executive compensation is not explicitly detailed in the provided data, but the 0% compensation from related parties suggests a focus on mission rather than excessive insider payments. Executive compensation data is sourced from IRS 990 filings, which require disclosure of officer, director, and key employee pay.
How has Massachusetts Biomedical Initiatives managed to achieve such consistent and substantial growth in both revenue and assets over the past seven years?
The data shows a steady increase in revenue from $1,776,600 in 2016 to $6,363,451 in 2023, and assets from $10,282,839 to $29,972,322 over the same period. This sustained growth suggests effective strategic planning, successful fundraising, and potentially increasing demand for its services within the biomedical sector.
Given the significant increase in total expenses from $1,693,667 in 2016 to $3,568,461 in 2023, what specific areas within 'programs' have seen the most substantial investment?
While the data indicates a high percentage of spending on programs (85%), the specific breakdown of program investments is not detailed. However, the overall increase in expenses suggests an expansion of services or increased operational costs associated with its growing mission.
Filing History
IRS 990 filing history for Massachusetts Biomedical Initiatives showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Massachusetts Biomedical Initiatives's revenue has grown by 359.1%, moving from $1.4M to $6.4M. Total assets increased by 205% over the same period, from $9.8M to $30.0M. Total functional expenses rose by 116.7%, from $1.6M to $3.6M. In its most recent filing year (2023), Massachusetts Biomedical Initiatives reported a surplus of $2.8M, with revenue exceeding expenses. The organization holds $9.1M in liabilities against $30.0M in assets (debt-to-asset ratio: 30.3%), resulting in net assets of $20.9M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $6.4M | $3.6M | $30.0M | $9.1M | — | — |
| 2022 | $4.8M | $3.4M | $23.7M | $6.8M | — | View 990 |
| 2021 | $4.3M | $2.9M | $18.5M | $672K | — | View 990 |
| 2020 | $6.0M | $2.2M | $17.5M | $842K | — | — |
| 2019 | $2.8M | $1.9M | $12.8M | $796K | — | View 990 |
| 2018 | $1.7M | $1.6M | $10.3M | $253K | — | View 990 |
| 2017 | $1.9M | $1.6M | $11.4M | $123K | — | — |
| 2016 | $1.8M | $1.7M | $10.3M | $176K | — | View 990 |
| 2015 | $1.6M | $1.7M | $10.4M | $500K | — | View 990 |
| 2014 | $2.1M | $1.8M | $10.8M | $657K | — | View 990 |
| 2013 | $2.0M | $1.8M | $10.8M | $708K | — | View 990 |
| 2012 | $1.8M | $1.3M | $10.8M | $1.4M | — | View 990 |
| 2011 | $1.4M | $1.6M | $9.8M | $1.6M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $6.4M, expenses of $3.6M, and assets of $30.0M (revenue +33.9% year-over-year).
- 2022: Revenue of $4.8M, expenses of $3.4M, and assets of $23.7M (revenue +9.6% year-over-year).
- 2021: Revenue of $4.3M, expenses of $2.9M, and assets of $18.5M (revenue -27.2% year-over-year).
- 2020: Revenue of $6.0M, expenses of $2.2M, and assets of $17.5M (revenue +111.5% year-over-year).
- 2019: Revenue of $2.8M, expenses of $1.9M, and assets of $12.8M (revenue +61.6% year-over-year).
- 2018: Revenue of $1.7M, expenses of $1.6M, and assets of $10.3M (revenue -7.0% year-over-year).
- 2017: Revenue of $1.9M, expenses of $1.6M, and assets of $11.4M (revenue +5.5% year-over-year).
- 2016: Revenue of $1.8M, expenses of $1.7M, and assets of $10.3M (revenue +11.6% year-over-year).
- 2015: Revenue of $1.6M, expenses of $1.7M, and assets of $10.4M (revenue -23.6% year-over-year).
- 2014: Revenue of $2.1M, expenses of $1.8M, and assets of $10.8M (revenue +5.8% year-over-year).
- 2013: Revenue of $2.0M, expenses of $1.8M, and assets of $10.8M (revenue +8.7% year-over-year).
- 2012: Revenue of $1.8M, expenses of $1.3M, and assets of $10.8M (revenue +30.7% year-over-year).
- 2011: Revenue of $1.4M, expenses of $1.6M, and assets of $9.8M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Massachusetts Biomedical Initiatives:
Data Sources and Methodology
This transparency report for Massachusetts Biomedical Initiatives is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.